Cryoport Inc. logo

Cryoport Inc. (CKX)

Market Closed
17 Jul, 20:00
XDUS XDUS
14. 50
+0.3
+2.1127%
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
-1.3 Eps
14.2
Previous Close
Add Transaction
Day Range
13.9 14.5
Year Range
5.6 14.5
Want to track CKX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CKX closed yesterday higher at €14.5, an increase of 2.1127% from Thursday's close, completing a monthly increase of 8.209% or €1.1. Over the past 12 months, CKX stock gained 82.3899%.
CKX is not paying dividends to its shareholders.
The last earnings report, released on Apr 30, 2026, exceeded the consensus estimates by 0.1802%. On average, the company has surpassed earnings expectations by 0.0743%, based on the last three reports.
Cryoport Inc. has completed 2 stock splits, with the recent split occurring on May 19, 2015.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

CKX Chart

Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript

Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript

Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates

CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.22 per share a year ago.

Zacks | 2 months ago
Cryoport: Moving Toward Commercial Scalability And Near-Term Breakeven

Cryoport: Moving Toward Commercial Scalability And Near-Term Breakeven

Cryoport receives a buy rating with a $9.1 price target, implying 17% upside by FY 2026. CYRX demonstrated double-digit revenue growth in Q4 2025, led by Life Sciences Services, and improved gross margins to 47.8%. Management targets positive adjusted EBITDA in H2 2026, supported by cost reductions and a strengthened partnership with DHL.

Seekingalpha | 3 months ago

Cryoport Inc. (CKX) FAQ

What is the stock price today?

The current price is €14.50.

On which exchange is it traded?

Cryoport Inc. is listed on XDUS.

What is its stock symbol?

The ticker symbol is CKX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Cryoport Inc. ever had a stock split?

Cryoport Inc. had 2 splits and the recent split was on May 19, 2015.

Cryoport Inc. Profile

Air Freight & Logistics Industry
Industrials Sector
Jerrell W. Shelton CEO
XDUS Exchange
US2290503075 ISIN
US Country
738 Employees
- Last Dividend
5 Feb 2010 Last Split
15 Mar 2005 IPO Date

Overview

Cryoport, Inc. is a pivotal player in the temperature-controlled supply chain industry, specializing in solutions for various sectors including biopharma/pharma, animal health, and human reproductive medicine. The company's reach spans across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, making it a global provider. Established in 1999 and headquartered in Brentwood, Tennessee, Cryoport has carved a niche in offering innovative and reliable logistics and storage solutions tailored for the management of temperature-sensitive biological materials.

Products and Services

  • Cryoport Express Shippers: Specialized shipping containers designed for the secure and temperature-controlled transport of biological materials.
  • Cryoport ELITE -80°C Gene Therapy Shipper: Advanced shipping solution catering specifically to the gene therapy sector, enabling safe transport at extremely low temperatures.
  • Cryoport ELITE Cryosphere Shipper: Another variant in the Cryoport ELITE series, these shippers are tailored for shipping materials that require maintenance of specific cold temperatures without the need for external power sources.
  • Cryoport Consulting Services: Offers expertise in the qualification of shipping systems, packaging solutions, and the development of custom packaging to meet client-specific needs across various temperature ranges.
  • Cryoport Bioservices: Comprehensive suite of services including controlled temperature storage, fulfilment, secondary packaging, and labelling of therapeutic products, alongside GMP raw materials storage services.
  • CRYOGENE Services: Specialized in the management of pre-clinical temperature-controlled biological materials encompassing specimen storage, collection, and retrieval processes.
  • CRYOPD: Offers a range of temperature-controlled logistics solutions ranging from cryogenic to controlled ambient packaging and transport solutions.
  • IntegriCell Services: Focuses on services like apheresis/leukapheresis collection, Cryoshuttle transportation, and cryo-process optimization, catering to the cell and gene therapy sectors.
  • MVE Biological Solutions' Fusion Cryogenic System: A self-sustaining cryogenic freezer designed for the secure storage of biological specimens at ultra-low temperatures.
  • MVE Biological Solutions' Vario Cryogenic System: Offers flexible temperature management between -20°C and -150°C, addressing a broad spectrum of cryogenic storage needs.
  • Cryoport Cryoshuttle: Provides dedicated local transportation support, enhancing the delivery and receipt of sensitive biological materials.
  • Tec4Med: Although not elaborated upon, it is indicated as part of Cryoport’s suite of solutions, likely representing a technology-driven service or product within the logistics and cryogenic storage domain.
  • Additional Services: Cryoport also offers an array of supplementary services including biological specimen cryopreservation, archiving, monitoring, tracking, receipt, delivery management of samples, and logistics and engineering consulting services.

Contact Information

Address: 112 Westwood Place
Phone: 949 470 2300